Try
Krystal Biotech Inc.
KRYSUnited States
35 filed reports · 378 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
35 reports · Sep 2017 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 27 | 3,446 | Sep 2017 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 8 | 2,743 | Dec 2017 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 351 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 4, 2026 | 213 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 17, 2026 | 795 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 3, 2025 | 221 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 133 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 139 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 19, 2025 | 327 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 4, 2024 | 146 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 5, 2024 | 120 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 6, 2024 | 120 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 26, 2024 | 342 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 6, 2023 | 124 | Open |
Financial data
378 concepts · 6,189 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial364 concepts · 6,066 facts · Mar 2016 to Jul 2026
- Accrued construction in progress51 · Dec 2018 to Jun 2026
- Cash and cash equivalents at carrying value50 · Sep 2016 to Jun 2026
- Depreciation50 · Sep 2016 to Jun 2026
- Net income loss50 · Sep 2016 to Jun 2026
- Operating expenses (US GAAP)50 · Sep 2016 to Jun 2026
- Operating income loss50 · Sep 2016 to Jun 2026
- Research and development expense50 · Sep 2016 to Jun 2026
- Common stock par or stated value per share49 · Dec 2016 to Jun 2026
- Increase decrease in accounts payable49 · Dec 2016 to Jun 2026
- Increase decrease in accrued liabilities and other operating liabilities49 · Dec 2016 to Jun 2026
- Share based compensation49 · Dec 2016 to Jun 2026
- Common stock shares authorized48 · Dec 2016 to Jun 2026
- Common stock shares issued48 · Dec 2016 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets48 · Dec 2016 to Jun 2026
- Share based compensation arrangement by share based payment award options grants in period gross48 · Dec 2016 to Jun 2026
- Accounts payable and other accrued liabilities current47 · Dec 2016 to Jun 2026
- Accounts payable current47 · Dec 2016 to Jun 2026
- Accumulated depreciation depletion and amortization property plant and equipment47 · Dec 2016 to Jun 2026
- Additional paid in capital47 · Dec 2016 to Jun 2026
- Assets47 · Dec 2016 to Jun 2026
- Assets current47 · Dec 2016 to Jun 2026
- Common stock shares outstanding47 · Dec 2016 to Jun 2026
- Common stock value47 · Dec 2016 to Jun 2026
- Liabilities47 · Dec 2016 to Jun 2026
Segment12 concepts · 110 facts · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Selling general and administrative expense13 · Dec 2023 to Jun 2026
- Reportable Segment12 · Dec 2022 to Jun 2026
- Litigation settlement expense11 · Dec 2023 to Dec 2025
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest8 · Dec 2023 to Jun 2026
- Income tax expense benefit7 · Dec 2023 to Jun 2026
- Interest income expense nonoperating net7 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)4 · Dec 2022 to Dec 2025
- Gain loss on disposition of intangible assets3 · Dec 2023 to Dec 2025
- Income loss attributable to parent3 · Dec 2022 to Dec 2024
Geography2 concepts · 13 facts · Dec 2016 to Jun 2026
- Revenue12 · Mar 2025 to Jun 2026
- Current federal tax expense benefit1 · Dec 2016
Segments
123 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 110 facts
- Reportable110 · Dec 2022 to Jun 2026
Statement geographicalsrt:StatementGeographicalAxis3 members · 12 facts
- Europe4 · Mar 2025 to Jun 2026
- JP4 · Mar 2025 to Jun 2026
- US4 · Mar 2025 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis1 member · 1 facts
- CA1 · Dec 2016
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary88 claims from 7 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary178 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes15 claims from 1 reports · Dec 2025
- Risk factors154 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · May 2026 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 3, 2026
- FY2026 Q1May 4, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.